Oragenics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.49

-0.02 (-3.02%)

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +953.7% upside

Low Target $3.59

Average Target $5.14

High Target $6.80

Current Price $0.49

Current
$0.49

Target
$5.14

$3.59 $5.14 avg $6.80

Scenario Analysis

Bear Case

$3.59

636.0%

Low target

Base Case

$5.14

+953.7%

Avg target

Bull Case

$6.80

+1,294.0%

High target

Risk/Reward

2.0x

Favorable

Price in Context

52-Week High

$1.45

-66.4% from high

52-Week Low

$0.48

+2.6% from low

Target vs 52W High

$5.14

+254.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.6%
AMGN Amgen Inc	Hold	43	47%	$190.87	-54.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+140.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-16.7%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-90.3%
MRNA Moderna Inc	Hold	30	37%	$149.45	-24.9%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-65.4%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.3%